Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.

Prostate carcinoma is the most common cancer in men. After local therapy, disease recurs in many patients. A choline PET/CT is indicated in case of biochemical relapse of prostate carcinoma to determine the site of recurrence (local and/or distant) and to help select the next line of therapy. Choline PET-CT is also known to show an elevated uptake in hyperfunctioning parathyroid adenoma. This case report shows the difficulty to distinguish between both entities if they occur simultaneously in an oncologic patient.

[1]  V. Lowe,et al.  ¹¹C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.

[2]  A. García-Vicente,et al.  Clinical utility of 18F‐fluorocholine positron‐emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study , 2015, BJU international.

[3]  M. Scorsetti,et al.  Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Andrea Ciarmiello,et al.  Clinical applications of choline PET/CT in brain tumors. , 2014, Current pharmaceutical design.

[5]  J. Talbot,et al.  Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? , 2014, The Journal of clinical endocrinology and metabolism.

[6]  J. Talbot,et al.  Use of choline PET for studying hepatocellular carcinoma , 2014, Clinical and Translational Imaging.

[7]  M. Picchio,et al.  Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse , 2012, Theranostics.

[8]  C. R. Hopkins,et al.  Thyroid and parathyroid imaging. , 1995, Seminars in ultrasound, CT, and MR.

[9]  S. Y. Kim,et al.  Sestamibi parathyroid imaging. , 1995, Seminars in nuclear medicine.

[10]  F. Montorsi,et al.  The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. , 2011, European urology.